A type of treatment that enables the patient’s own immune system to fight cancer, infections, or other diseases. Cancer immunotherapies are also known as immuno-oncology
LATEST ARTICLES
Do Tumors Hold the Key to Their Own Destruction?
By studying the interactions between a tumor and a patient's immune system, researchers at biopharmaceutical companies such as Bristol-Myers Squibb (BMS) are trying to reduce the ambiguity involved in fighting cancer.
A Pipeline of Promise: Immuno-oncology
We are in a new era of medicine, powered in part by the advancements and innovations being made in the field of immuno-oncology or immunotherapy
More Than 240 Immuno-oncology Treatments in Development to Fight Cancer
The need for new cancer treatments is more important than ever, and America's biopharmaceutical companies are boldly leading the way in discovering new breakthroughs.
Targeting the Immune System, Not the Tumor
Immuno-oncology is based on the concept of harnessing the body's own immune system to fight cancer, and recent scientific discoveries and clinical advances have ushered in a truly historical time in cancer research.
A New Way to Fight Cancer
It used to be science fiction. Harnessing your body's own immune system to fight cancer. But what was once the fruit of a wild imagination is today a reality.
Advancing Our Knowledge and Understanding of Cancer
After centuries without viable cancer treatments, scientists are more hopeful than ever before as they learn more about different types of the disease. We're taking a look at the advancements that have occurred over the last decade.
RELATED ARTICLES
4 Revolutionary Approaches Contributing to the Drop in Cancer Mortality Rate
Since peaking in 1991, the death rate associated with cancer declined by 29%, which translates to 2.9 million fewer cancer deaths.
Researcher Profile: Rebecca Leary
Rebecca Leary works at the forefront of precision medicine, pursuing technologies that characterize cancer cells and their relationship with the body's own immune system.
Researcher Profile: Nils Lonberg
In his role as senior vice president of oncology biology discovery at Bristol-Myers Squibb, Dr. Lonberg leads a drug discovery group responsible for identifying potential immuno-oncology (I-O) treatments.
Looking Ahead Toward a Bright Future
Today, August 1, marks World Lung Cancer Day, which aims to raise awareness not only of the devastating effects of the disease, but also of the hope provided to patients through advances in treatments we’ve made in previous years.
Researcher Profile: Axel Hoos
"In simple terms, we're making new medicines that can have a transformational impact on cancer," says Dr. Axel Hoos about his day-to-day work.
Lung Cancer Gets Personal
Lung cancer counts for 25% of all cancer deaths in the U.S. That's why every day, researchers search relentlessly to unearth more innovative breakthroughs. Thanks to their dedication, there are now 240 immuno-oncology treatments in development to give hope and a future for patients with cancer.
Researcher Profile: Maysoun Shomali
As a research investigator at Sanofi, Maysoun Shomali is a pioneer making a difference for breast cancer research.
Outsmarting Breast Cancer
Thanks to advances in modern medicine, there has been significant progress for breast cancer patients in the last decade. Groundbreaking innovations in personalized medicine are changing the course of treatment to create potential first-in-class therapies and the promise of a cancer-free future.
Change on the Horizon: The Future of Cancer Treatment
Experts and thought leaders touching every aspect of cancer came together for "Future Shapers: A New Era in Cancer Care", a conversation led by Axios and part of PhRMA's GoBoldly Campaign.
Sharing Bold Advancements: Doreen Gentzler
Doreen Gentzler has a long, successful career not only in broadcast journalism but also in promoting public health issues. Today, she is a local NBC anchor in Washington, DC, and she serves as the station's medical reporter, filing cutting-edge health reports for all of the station's newscasts.
Harnessing the Power of the Body's Own Immune System
America's biopharmaceutical companies are working to harness the power of the body's own immune system to fight not only infectious diseases, but cancers such as leukemia and lymphoma.
Researcher Profile: Christina Trout
Christina works in the Epigenetic Department at Celgene as a research scientist, exploring a number of cancer indications.
A New World of Medicine
Join us on a journey deep into the new frontier of medicine. Explore how immunotherapy can take the place of chemotherapy and how medicines once made for the masses are now designed specifically for you.
The Science Behind the Logo
America's biopharmaceutical companies are driving the future of medicine through bold advances in genomics, personalized medicine and immunotherapy. Through these innovative methods, researchers hope to help patients live longer, healthier, and more productive lives.
